AI Engines For more Details: Perplexity Kagi Labs You
Headache: Headache is one of the most common side effects reported by individuals taking ondansetron. It may range from mild to severe and can sometimes interfere with daily activities.
Constipation: Ondansetron can slow down bowel movements and lead to constipation, especially when used for an extended period. Increasing fluid intake and dietary fiber may help alleviate this side effect.
Fatigue: Some people may experience fatigue or tiredness while taking ondansetron. This side effect can affect daily functioning and may require adjustments to activities or rest periods.
Dizziness: Ondansetron may cause dizziness or lightheadedness in some individuals, especially when standing up quickly from a sitting or lying position. It's important to rise slowly to minimize the risk of falls.
Diarrhea: While less common than constipation, some individuals may experience diarrhea as a side effect of ondansetron. This side effect is usually mild and resolves on its own in most cases.
Abdominal pain: Ondansetron can sometimes cause abdominal discomfort or pain, which may include cramping, bloating, or discomfort in the stomach area.
Changes in liver function: In rare cases, ondansetron may affect liver function and lead to abnormal liver enzyme levels. This side effect is more common in individuals with preexisting liver conditions.
Allergic reactions: Although rare, some people may experience allergic reactions to ondansetron, including rash, itching, swelling of the face or throat, difficulty breathing, or dizziness. Seek immediate medical attention if you experience any signs of an allergic reaction.
Serotonin syndrome: Ondansetron can increase serotonin levels in the brain, particularly when used in combination with other medications that affect serotonin. Serotonin syndrome is a potentially life-threatening condition characterized by symptoms such as agitation, confusion, rapid heart rate, high blood pressure, sweating, tremors, and fever.
QT prolongation: Ondansetron may prolong the QT interval on an electrocardiogram (ECG), which can increase the risk of abnormal heart rhythms, including a type of arrhythmia called torsades de pointes. This risk may be higher in individuals with preexisting heart conditions or those taking other medications known to prolong the QT interval.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Bacteroides uniformis | Reduces |
| species | Escherichia coli | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Abdominal Aortic Aneurysm | 0.3 | 0.3 | |
| ADHD | 1.6 | 0.3 | 4.33 |
| Age-Related Macular Degeneration and Glaucoma | 0.5 | 0.4 | 0.25 |
| Allergic Rhinitis (Hay Fever) | 1.9 | 0.5 | 2.8 |
| Allergies | 1.8 | 0.9 | 1 |
| Allergy to milk products | 1 | 1.3 | -0.3 |
| Alzheimer's disease | 2.1 | 4 | -0.9 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.9 | 0.5 | 0.8 |
| Ankylosing spondylitis | 1.6 | 1.2 | 0.33 |
| Anorexia Nervosa | 0.4 | 1.1 | -1.75 |
| Antiphospholipid syndrome (APS) | 1.1 | 0.3 | 2.67 |
| Asthma | 1.6 | 0.8 | 1 |
| Atherosclerosis | 1 | 1.1 | -0.1 |
| Atrial fibrillation | 1.3 | 2.1 | -0.62 |
| Autism | 4.4 | 3.8 | 0.16 |
| Autoimmune Disease | 0.6 | 0.5 | 0.2 |
| Barrett esophagus cancer | 0.3 | 0.3 | |
| benign prostatic hyperplasia | 0.6 | 0.3 | 1 |
| Biofilm | 1.2 | 1.2 | |
| Bipolar Disorder | 1.6 | 0.8 | 1 |
| Brain Trauma | 0.8 | -0.8 | |
| Breast Cancer | 0.6 | 0.6 | |
| Cancer (General) | 0.3 | 0.3 | |
| Carcinoma | 2.1 | 0.7 | 2 |
| Celiac Disease | 1.5 | 1 | 0.5 |
| Cerebral Palsy | 0.3 | 0.8 | -1.67 |
| Chronic Fatigue Syndrome | 2 | 2.1 | -0.05 |
| Chronic Kidney Disease | 2.5 | 1.9 | 0.32 |
| Chronic Lyme | 0.8 | -0.8 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 1 | 1.1 | -0.1 |
| Chronic Urticaria (Hives) | 1.1 | 0.3 | 2.67 |
| Coagulation / Micro clot triggering bacteria | 1.5 | 0.5 | 2 |
| Cognitive Function | 0.7 | 0.5 | 0.4 |
| Colorectal Cancer | 3.5 | 1.9 | 0.84 |
| Constipation | 1 | 0.5 | 1 |
| Coronary artery disease | 1.9 | 1.3 | 0.46 |
| COVID-19 | 2.3 | 3.3 | -0.43 |
| Crohn's Disease | 4.2 | 2 | 1.1 |
| Cushing's Syndrome (hypercortisolism) | 0.4 | -0.4 | |
| cystic fibrosis | 1.1 | 0.8 | 0.38 |
| d-lactic acidosis (one form of brain fog) | 0.5 | 0.5 | |
| deep vein thrombosis | 1.5 | 0.8 | 0.88 |
| Denture Wearers Oral Shifts | 0.2 | 0.2 | |
| Depression | 3.7 | 3.8 | -0.03 |
| Eczema | 1.5 | 1.5 | |
| Endometriosis | 2.1 | 1.3 | 0.62 |
| Eosinophilic Esophagitis | 0.3 | 0.3 | |
| Epilepsy | 1.6 | 0.8 | 1 |
| erectile dysfunction | 1.2 | 1.2 | |
| Fibromyalgia | 1 | 1.2 | -0.2 |
| Functional constipation / chronic idiopathic constipation | 2.8 | 2.5 | 0.12 |
| gallstone disease (gsd) | 2.1 | 0.8 | 1.63 |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.6 | 0.6 | |
| Generalized anxiety disorder | 2.5 | 0.6 | 3.17 |
| Gout | 0.8 | 0.3 | 1.67 |
| Graves' disease | 0.7 | 1.1 | -0.57 |
| Gulf War Syndrome | 0.3 | 0.3 | |
| Halitosis | 0.8 | 0.8 | |
| Hashimoto's thyroiditis | 1.7 | 1.2 | 0.42 |
| Heart Failure | 2.8 | 0.7 | 3 |
| hemorrhagic stroke | 0.7 | 0.7 | |
| Hidradenitis Suppurativa | 0.9 | 0.9 | |
| High Histamine/low DAO | 1 | 1 | |
| hypercholesterolemia (High Cholesterol) | 0.5 | 0.5 | |
| hyperglycemia | 1.1 | 0.7 | 0.57 |
| Hyperlipidemia (High Blood Fats) | 0.3 | 0.3 | |
| hypersomnia | 0.3 | -0.3 | |
| hypertension (High Blood Pressure | 2 | 1.4 | 0.43 |
| Hypothyroidism | 0.3 | -0.3 | |
| Hypoxia | 1.8 | 1.8 | |
| IgA nephropathy (IgAN) | 1 | 1.5 | -0.5 |
| Inflammatory Bowel Disease | 3 | 3.8 | -0.27 |
| Insomnia | 0.6 | 1.1 | -0.83 |
| Intelligence | 1.1 | 0.3 | 2.67 |
| Intracranial aneurysms | 1 | 0.3 | 2.33 |
| Irritable Bowel Syndrome | 3.3 | 1.7 | 0.94 |
| ischemic stroke | 1.2 | 1.7 | -0.42 |
| Liver Cirrhosis | 3.5 | 2.2 | 0.59 |
| Long COVID | 3.5 | 2.4 | 0.46 |
| Low bone mineral density | 0.8 | -0.8 | |
| Lung Cancer | 0.9 | 0.9 | |
| Lymphoma | 0.6 | 0.6 | |
| Mast Cell Issues / mastitis | 0.8 | 0.3 | 1.67 |
| ME/CFS with IBS | 0.3 | 0.9 | -2 |
| ME/CFS without IBS | 0.6 | 0.3 | 1 |
| Menopause | 0.5 | -0.5 | |
| Metabolic Syndrome | 4.4 | 2.3 | 0.91 |
| Mood Disorders | 3 | 3.2 | -0.07 |
| Multiple Sclerosis | 1.8 | 2 | -0.11 |
| myasthenia gravis | 0.6 | 0.5 | 0.2 |
| neuropathic pain | 1.3 | -1.3 | |
| Neuropathy (all types) | 1.6 | -1.6 | |
| neuropsychiatric disorders (PANDAS, PANS) | 0.5 | 0.5 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 2.5 | 1.3 | 0.92 |
| NonCeliac Gluten Sensitivity | 0.3 | 0.3 | 0 |
| Obesity | 4.7 | 2.6 | 0.81 |
| obsessive-compulsive disorder | 2 | 2.4 | -0.2 |
| Osteoarthritis | 1.5 | 0.3 | 4 |
| Osteoporosis | 1.4 | 0.3 | 3.67 |
| pancreatic cancer | 0.2 | 0.2 | |
| Parkinson's Disease | 3.5 | 3.3 | 0.06 |
| Polycystic ovary syndrome | 3.2 | 1.1 | 1.91 |
| Postural orthostatic tachycardia syndrome | 0.3 | -0.3 | |
| Premenstrual dysphoric disorder | 0.4 | -0.4 | |
| primary biliary cholangitis | 0.3 | -0.3 | |
| Primary sclerosing cholangitis | 1 | 1.3 | -0.3 |
| Psoriasis | 0.5 | 2 | -3 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 3.5 | 1.6 | 1.19 |
| Rosacea | 0.6 | 0.5 | 0.2 |
| Schizophrenia | 1.6 | 1.6 | 0 |
| scoliosis | 0.7 | 0.3 | 1.33 |
| Sjögren syndrome | 1.3 | 1.1 | 0.18 |
| Sleep Apnea | 0.6 | 1.1 | -0.83 |
| Slow gastric motility / Gastroparesis | 0.7 | 0.7 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 1.3 | 1.3 | |
| Stress / posttraumatic stress disorder | 2 | 1.6 | 0.25 |
| Systemic Lupus Erythematosus | 2.8 | 0.5 | 4.6 |
| Tic Disorder | 0.2 | 0.3 | -0.5 |
| Tourette syndrome | 0.3 | -0.3 | |
| Type 1 Diabetes | 1.6 | 1 | 0.6 |
| Type 2 Diabetes | 4.8 | 2.5 | 0.92 |
| Ulcerative colitis | 2.1 | 2.3 | -0.1 |
| Unhealthy Ageing | 3 | 1.4 | 1.14 |
| Vitiligo | 0.7 | 1 | -0.43 |
